Navigation Links
MEDai Technology Identifies Prescription Drug Misuse
Date:7/2/2008

ORLANDO, Fla., July 2 /PRNewswire/ -- MEDai, Inc., headquartered in Orlando, FL, is a leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics to offer a robust suite of predictive modeling solutions that address the needs of health plans, employers, physicians, underwriters and actuaries. Risk Navigator Clinical(R), provides several reports that focus on the identification of potential misuse of prescription drugs, a subject that has quickly climbed to the top of the concerns list for those in the payer space.

"Pharmacy costs are increasing at an alarming rate and stakeholders are searching for ways to reduce their costs without sacrificing the quality of care being delivered," said Swati Abbott, President of MEDai. "It was apparent to us that as an information broker, gathering and processing data from various healthcare sources, we were in a position to help our clients address this very real concern," she added. "With a few clicks clients can identify those individuals receiving large quantities of narcotics or who may be attempting to hide excessive controlled substance abuse by obtaining drugs from multiple physicians," she concluded.

For more than a decade, MEDai's Risk Navigator Clinical has accurately identified prospective high- risk patients to help its clients improve member health and quality of care while controlling cost. Risk Navigator Clinical also predicts inpatient stays; ER visits, pharmacy costs, and provides chronic and acute cost avoidance scores in addition to analyzing evidence-based guideline medicine compliance. These predictions allow care management efforts to be focused on members whose costs can be impacted through early intervention.

About MEDai

MEDai, Inc. is a subsidiary of Elsevier a world-leading publisher of scientific, technical and medical information products and services. For more than a decade MEDai has been offering award-winning solutions for the improvement of healthcare delivery. Utilizing cutting-edge technology, payers and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate patient patterns over time, and improve outcomes. For more information on MEDai, visit http://www.medai.com.

For More Information Contact:

Lizzy Feliciano, MBA,

Manager

Marketing & Communications

MEDai, Inc.

(800) 446-3324


'/>"/>
SOURCE MEDai, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MEDai Demonstrates the Value of Implementing Predictive Analytics
2. MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling
3. MEDai Client Named Recipient of 2007 Malcolm Baldrige National Quality Award
4. Leading Childrens Hospital Utilizes MEDais Solutions to Deliver Outstanding Care
5. MedAire to Provide Medical Training for Bombardier Safety Standdown
6. Virgin America Airline Debuts With MedAire Services
7. Align Technology to Announce Second Quarter Fiscal 2008 Results on July 29
8. Samplify Systems Announces Distribution Agreement With Tokyo Electron Device Limited, Broadening Availability of Signal Compression Technology
9. BPO Management Services Wins Two New Information Technology Outsourcing Contracts
10. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
11. Toys and technology for rehabilitation in cerebral palsy patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... a new partnership with the Rhode Island Consortium for Autism Research and Treatment ... opportunity for children with autism spectrum disorder (ASD) to see films in an ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When ... new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. ... healthcare systems recently invested $51 million to purchase and renovate the 185,000 square-foot ...
(Date:2/22/2017)... Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... detox treatment to the thousands of individuals who have recently fallen victim to America’s ... hospital in Orange County, California, where they are free from the shame, stigma, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... leads to fewer trips the emergency room, fewer hospital admissions, and better blood ... of Managed Care® (AJMC®) finds. The study can be found here . ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017   SeraCare Life ... global in vitro diagnostics manufacturers and clinical laboratories, ... "Catalyzing Implementation of NGS-Based Tests" to be hosted ... 2017 at 11am Eastern Standard Time (US). ... highlight the need for improved performance and global ...
(Date:2/23/2017)... -- ML Capital Group, Inc. (USOTC: MLCG) today announced ... , a Colorado -based cannabis tourism company. ... (USOTC: PURA) to enter Colorado,s $19 billion ... Tours acquisition announced today is intended to accelerate MLCG,s ... ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
Breaking Medicine Technology: